Skip to content

Clinical trials

Cognition Disorders trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognition Disorders Phase: Not applicable Clear all

167 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20043
20051
20062
20074
20081
20091
20102
20115
20124
20136
201412
20154
201612
201710
20189
20196
20208
202111
202213
202313
202412
20259
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed77
Recruiting25
Unknown status23
Not yet recruiting13
Withdrawn10
Active, not recruiting9
Terminated8
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pittsburgh4
Tri-Service General Hospital (TSGH)3
Universita di Verona3
University of California, San Francisco3
Amsterdam UMC, location VUmc2
Beth Israel Deaconess Medical Center2
Biruni University2
Centre Hospitalier Universitaire Vaudois2
Centre d'Investigation Clinique et Technologique 8052
Duke University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognition Disorders167
Cognitive Dysfunction36
Schizophrenia20
Dementia14
Stroke14
Memory Disorders12
Alzheimer Disease11
Neurocognitive Disorders10
Psychotic Disorders9
Brain Injuries, Traumatic8

Trials

Showing 76 to 100 of 167. Each trial links to its page on Pharma Observatory.

67 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.